Responses in multiple myeloma should be assigned according to serum, not urine, free light chain measurements

The most recent update to the International Myeloma Working Group consensus criteria places a strong emphasis on the need for more sensitive haematological markers of response driven by the success of novel therapies. One such marker is serum free light chain (sFLC) analysis, which was first incorpo...

Descripción completa

Detalles Bibliográficos
Autores principales: Dejoie, Thomas, Corre, Jill, Caillon, Helene, Moreau, Philippe, Attal, Michel, Loiseau, Hervé Avet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6365491/
https://www.ncbi.nlm.nih.gov/pubmed/30573778
http://dx.doi.org/10.1038/s41375-018-0339-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6365491/
https://www.ncbi.nlm.nih.gov/pubmed/30573778
http://dx.doi.org/10.1038/s41375-018-0339-y

Ejemplares similares